TARGETING THE ABERRANT ANDROGEN RECEPTOR IN ADVANCED TREATMENT-RESISTANT PROSTATE CANCER

$6,507,986FY2013Department of the ArmyDOD

University Of Washington, Seattle WA

Investigators